Total trials
213
Active
18
Phase 3
9
Total enrollment
44,358
Pipeline matrix
Showing 8 of 8 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| GnRH agonist | — | — | — | — | — | 1 | |
| Ursolvan | — | — | — | — | — | 1 | |
| Dostarlimab | — | — | — | — | — | 1 | |
| Vitamin D3 | — | — | — | — | — | 1 | |
| mFOLFIRINOX Treatment Regimen | — | — | — | — | — | 1 | |
| LV5FU2 | — | — | — | — | — | 1 | |
| Metformin | — | — | — | — | — | 1 | |
| Temozolomide | — | — | — | — | — | 1 |
Next readouts
- 2026-06-18
- 2027-05
- 2028-02-18
- 2028-05
Top conditions
- Anesthesia27
- Pain8
- Anesthesia, General7
- Surgery7
- General Anesthesia6
- Bladder Cancer4
- Lung Transplant4
- Covid194
Frequently asked questions about Hopital Foch
- How many clinical trials does Hopital Foch have on ClinicalTrials.gov?
- Hopital Foch is listed as the lead sponsor on 213 clinical trials in ClinicalTrials.gov, 18 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hopital Foch's trials are in Phase 3?
- 9 of Hopital Foch's trials are in Phase 3, spread across 8 active drug programs.
- What therapeutic areas does Hopital Foch focus on?
- Hopital Foch's most-studied conditions on ClinicalTrials.gov are Anesthesia, Pain, Anesthesia, General, Surgery, General Anesthesia.
- When are Hopital Foch's next clinical trial readouts?
- Hopital Foch has 4 upcoming primary-completion readouts tracked here; the soonest is “Benefit of GnRH Agonist Before Frozen Embryo Transfer in Patients With Endometriosis and/or Adenomyosis”, expected around 2026-06-18.